Starton Therapeutics (Starton Therapeutics) Cash And Cash Equivalents : $1.35 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Cash And Cash Equivalents?

Starton Therapeutics's quarterly cash and cash equivalents increased from Dec. 2022 ($0.07 Mil) to Mar. 2023 ($0.14 Mil) and increased from Mar. 2023 ($0.14 Mil) to Jun. 2023 ($1.35 Mil).

Starton Therapeutics's annual cash and cash equivalents declined from Mar. 2021 ($3.69 Mil) to Mar. 2022 ($0.33 Mil) and declined from Mar. 2022 ($0.33 Mil) to Mar. 2023 ($0.14 Mil).

Starton Therapeutics Cash And Cash Equivalents Historical Data

The historical data trend for Starton Therapeutics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Cash And Cash Equivalents Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Cash And Cash Equivalents

3.69

0.33

0.14

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Cash And Cash Equivalents	Get a 7-Day Free Trial			0.33	-	0.07	0.14	1.35

Starton Therapeutics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Starton Therapeutics (NAS:STA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Starton Therapeutics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines